Red Flags That Signal Unsuitable Trial Sites During Feasibility Assessments
Red Flags That Signal Unsuitable Trial Sites During Clinical Trial Feasibility Successful clinical trial execution begins with robust feasibility assessments that identify high-performing, compliant investigational sites. However, not all sites are created equal. Even experienced investigators may be operating in environments that pose significant risks to patient safety, data quality, or regulatory compliance. Identifying red…
Read More “Red Flags That Signal Unsuitable Trial Sites During Feasibility Assessments” »